Dilution of Share Value Through the Exercise of Stock Acquisition Rights
First written in FY2022. 3 of 8 entries say "Mitigated", first in FY2023. Latest entry: 2026-05-19.
The whole theme swung hardest in 2017: 29 of 55 companies on the "Worse" side.
33 other companies' latest entry also says "Worsened".
- 2026-05-19WorsenedOccurring Fact
「Although this third-party allotment will result in dilution, we have determined that pursuing various business initiatives through the business alliance with the intended allottee made possible by the third-party allotment will contribute to increasing the Company’s corporate value and share value.」
The planned third-party allotment dated 31 July 2026 was disclosed as involving the issuance of shares equivalent to 23.99% of issued shares and anticipated dilution. - FY2026MitigatedAnnual report
「The Company has granted stock acquisition rights covering 366,000 shares to directors, officers and employees as an incentive to increase corporate value over the long term, equivalent to 2.6% of the total number of issued shares.」
The potential number of shares was 366,000, equivalent to 2.6% of the total number of issued shares, down from 470,000 shares and 3.4% in the previous fiscal year. - FY2025MitigatedAnnual report
「The Company has granted stock acquisition rights covering 470,000 shares to directors, officers and employees as an incentive to increase corporate value over the long term, equivalent to 3.4% of the total number of issued shares.」
The potential number of shares was 470,000, equivalent to 3.4% of the total number of issued shares, down from 525,000 shares and 3.8% as reported for the previous fiscal year. At the same time, the Company is considering additional grants in the future. - FY2024MaterialisedAnnual report
「The 92,000-share increase in issued common shares resulted from the exercise of stock acquisition rights granted as stock options.」
Shares were issued during the fiscal year through the exercise of stock acquisition rights, increasing the total number of issued shares from 13,874,000 to 13,966,000. - FY2024-Q3MaterialisedAnnual report
「During the nine months ended 31 December, the Company received payment upon the exercise of the first and second series of stock acquisition rights.」
The exercise of stock acquisition rights continued, and the total number of issued shares increased from 13,874,000 at the end of the previous fiscal year to 13,966,000. The potential increase in the number of shares materialised. - FY2024-Q1MaterialisedAnnual report
「This was due to the exercise of stock acquisition rights.」
During the quarter, the total number of issued shares increased by 92,000 shares through the exercise of stock acquisition rights, resulting in an actual increase in the potential number of shares. - FY2023MitigatedAnnual report
「The Company granted directors and employees stock acquisition rights covering 525,000 shares, equivalent to 3.8% of the total number of shares issued, as an incentive to increase corporate value over the long term.」
The remaining stock acquisition rights declined from 969,000 shares, or 8.0%, as reported for FY2022, to 525,000 shares, or 3.8%. The risk itself continues to be recognized. - FY2022First statedAnnual report
「The Company granted stock options covering 969,000 shares, equivalent to 8.0% of the total number of shares issued.」
Identifies as risks the increase in the number of shares issued through the exercise of stock acquisition rights, the balance of supply and demand, and the impact on share price formation.